An Analytical Reference Standard
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Carisoprodol

Item No. 30778

Synonyms
Synonyms
  • NIH 10966
  • NSC 172124
Technical Information
Formal Name
N-(1-methylethyl)-carbamic acid, 2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester
CAS Number
78-44-4
Molecular Formula
C12H24N2O4
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMSO: 10 mg/mlEthanol: 20 mg/mlEthanol:PBS (pH 7.2) (1:1): 0.5 mg/ml
SMILES
CC(C)NC(OCC(CCC)(C)COC(N)=O)=O
InChi Code
InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)
InChi Key
OFZCIYFFPZCNJE-UHFFFAOYSA-N
Regulatory Information
DEA Schedule
IV
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    Carisoprodol (Item No. 30778) is an analytical reference standard categorized as a skeletal muscle relaxant.1 It also has sedative properties.2 Carisoprodol is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Reeves, R.R., Burke, R.S., and Kose, S. Carisoprodol: Update on abuse potential and legal status. South Med. J. 105(11), 619-623 (2012).

    2. Gonzalez, L.A., Gatch, M.B., Taylor, C.M., et alCarisoprodol-mediated modulation of GABAA receptors: In vitro and in vivo studies. J. Pharmacol. Exp. Ther. 329(2), 827-837 (2009).